Table 2.
Main medication changes before and after the implementation of the DITSMI model
N = 702 prescriptions, 417 changes | Before | After | p value |
---|---|---|---|
First-generation antipsychotic medication | 81 (22.1%) | 42 (12.9%) | <0.001 |
Second-generation antipsychotic medication | 64 (21.2%) | 100 (30.7%) | <0.001 |
Clozapine | 44 (12.0%) | 60 (18.2%) | 0.021 |
Olanzapine | 14 (3.8%) | 36 (11.1%) | 0.003 |
Biperideen | 46 (19.9%) | 24 (12.9%) | 0.026 |
Benzodiazepines | 101 (27.2%) | 99 (29.8%) | 0.459 |
Lorazepam | 36 (7.1%) | 52 (16%) | 0.018 |
Oxazepam | 43 (11.7%) | 23 (7.1%) | 0.033 |
Anticonvulsants | 33 (9.0%) | 29 (8.9%) | 0.931 |
Antidepressant medication | 34 (9.2%) | 24 (7.3%) | 0.346 |
SSRI | 24 (6.5%) | 19 (5.8%) | 0.673 |
Tri-cyclic antidepressant | 10 (2.7%) | 5 (1.5%) | 0.273 |
Number of prescriptions (denominator) | 370 | 332 |
Abbreviations: DITSMI, Diagnose, Indicate, Treat, Severe Mental Illness; SSRI, selective serotonin reuptake inhibitors.